Overview

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

Status:
RECRUITING
Trial end date:
2025-02-20
Target enrollment:
Participant gender:
Summary
Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of this study is to evaluate the efficacy and safety of the drug combination of Ibuprofen/Loratadine versus Ibuprofen versus Loratadine as monotherapy for the symptomatic treatment of the common cold.
Phase:
PHASE3
Details
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Treatments:
Ibuprofen
Loratadine